Meeder Asset Management Inc Emergent Bio Solutions Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 5,363 shares of EBS stock, worth $45,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,363

Previous 6,051 11.37%

Holding current value

$45,156

Previous $41,000 7.32%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$5.72 - $14.77 $3,935 - $10,161	-688 Reduced 11.37%	5,363 $44,000
Q2 2024 Aug 08, 2024	BUY	$1.86 - $6.98 $11,254 - $42,235	6,051 New	6,051 $41,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $4,345 - $8,472	395 Added 20.08%	2,362 $27,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $37,849 - $67,447	1,884 Added 2269.88%	1,967 $42,000
Q2 2022 Aug 08, 2022	SELL	$27.42 - $43.63 $28,324 - $45,069	-1,033 Reduced 92.56%	83 $3,000
Q1 2022 May 10, 2022	BUY	$36.48 - $52.22 $40,711 - $58,277	1,116 New	1,116 $46,000
Q4 2021 Feb 11, 2022	SELL	$33.11 - $55.01 $15,925 - $26,459	-481 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$50.07 - $66.05 $163,278 - $215,389	-3,261 Reduced 87.15%	481 $24,000
Q2 2021 Aug 09, 2021	BUY	$56.61 - $80.46 $32,041 - $45,540	566 Added 17.82%	3,742 $236,000
Q1 2021 Apr 28, 2021	BUY	$86.23 - $125.19 $265,071 - $384,834	3,074 Added 3013.73%	3,176 $295,000
Q4 2020 Feb 09, 2021	SELL	$79.17 - $111.47 $351,039 - $494,257	-4,434 Reduced 97.75%	102 $9,000
Q3 2020 Nov 02, 2020	SELL	$81.91 - $134.94 $94,687 - $155,990	-1,156 Reduced 20.31%	4,536 $469,000
Q2 2020 Aug 11, 2020	SELL	$54.33 - $89.52 $15,375 - $25,334	-283 Reduced 4.74%	5,692 $450,000
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $127,395 - $177,538	2,582 Added 76.1%	5,975 $346,000
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $119,831 - $138,200	2,340 Added 222.22%	3,393 $182,000
Q3 2019 Oct 17, 2019	SELL	$40.6 - $57.2 $139,664 - $196,768	-3,440 Reduced 76.56%	1,053 $55,000
Q2 2019 Aug 05, 2019	SELL	$39.92 - $53.86 $116,406 - $157,055	-2,916 Reduced 39.36%	4,493 $216,000
Q1 2019 Apr 16, 2019	SELL	$48.23 - $66.16 $105,913 - $145,287	-2,196 Reduced 22.86%	7,409 $375,000
Q4 2018 Jan 17, 2019	SELL	$55.63 - $73.24 $80,440 - $105,905	-1,446 Reduced 13.08%	9,605 $570,000
Q3 2018 Nov 02, 2018	SELL	$52.05 - $66.51 $350,036 - $447,279	-6,725 Reduced 37.83%	11,051 $0
Q2 2018 Jul 24, 2018	BUY	$48.33 - $55.64 $674,541 - $776,567	13,957 Added 365.46%	17,776 $0
Q1 2018 May 03, 2018	SELL	$44.44 - $54.39 $103,189 - $126,293	-2,322 Reduced 37.81%	3,819 $201,000
Q4 2017 Feb 02, 2018	BUY	$37.77 - $47.75 $53,217 - $67,279	1,409 Added 29.78%	6,141 $285,000
Q3 2017 Oct 20, 2017	BUY	$34.14 - $40.45 $161,550 - $191,409	4,732	4,732 $191,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Emergent Bio Solutions Inc. Transaction History